Robert Straßl

2.9k total citations · 1 hit paper
92 papers, 1.6k citations indexed

About

Robert Straßl is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Robert Straßl has authored 92 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Infectious Diseases, 36 papers in Epidemiology and 20 papers in Hepatology. Recurrent topics in Robert Straßl's work include SARS-CoV-2 and COVID-19 Research (19 papers), COVID-19 Clinical Research Studies (18 papers) and Hepatitis C virus research (16 papers). Robert Straßl is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (19 papers), COVID-19 Clinical Research Studies (18 papers) and Hepatitis C virus research (16 papers). Robert Straßl collaborates with scholars based in Austria, Germany and Finland. Robert Straßl's co-authors include Michael Kundi, Alan D. Kaye, Michael Frass, Helmut Friehs, Gregor Bond, Elisabeth Puchhammer‐Stöckl, Konstantin Doberer, Irene Görzer, Georg A. Böhmig and Željko Kikić and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Robert Straßl

85 papers receiving 1.6k citations

Hit Papers

Use and acceptance of complementary and alternative medic... 2012 2026 2016 2021 2012 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Straßl Austria 18 470 469 316 300 220 92 1.6k
Francesca Fortunato Italy 26 521 1.1× 234 0.5× 70 0.2× 37 0.1× 60 0.3× 112 1.8k
Nicolas Jovenin France 20 430 0.9× 176 0.4× 47 0.1× 29 0.1× 207 0.9× 61 1.5k
Katia Falasca Italy 22 389 0.8× 421 0.9× 21 0.1× 200 0.7× 86 0.4× 92 1.4k
Gabriella Pár Hungary 24 498 1.1× 262 0.6× 14 0.0× 371 1.2× 169 0.8× 85 1.9k
Cristina Oana Mărginean Romania 21 315 0.7× 123 0.3× 16 0.1× 44 0.1× 52 0.2× 128 1.3k
Yunfeng Wang China 20 240 0.5× 170 0.4× 23 0.1× 8 0.0× 188 0.9× 74 1.6k
Hongmei Yang China 25 867 1.8× 189 0.4× 16 0.1× 46 0.2× 43 0.2× 123 1.8k
Patrick Ten Eyck United States 18 205 0.4× 799 1.7× 13 0.0× 14 0.0× 170 0.8× 98 1.7k
Mehmet Rami Helvacı Türkiye 21 256 0.5× 67 0.1× 10 0.0× 69 0.2× 43 0.2× 148 1.4k
Michele Miraglia del Giudice Italy 28 286 0.6× 198 0.4× 37 0.1× 24 0.1× 36 0.2× 234 2.8k

Countries citing papers authored by Robert Straßl

Since Specialization
Citations

This map shows the geographic impact of Robert Straßl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Straßl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Straßl more than expected).

Fields of papers citing papers by Robert Straßl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Straßl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Straßl. The network helps show where Robert Straßl may publish in the future.

Co-authorship network of co-authors of Robert Straßl

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Straßl. A scholar is included among the top collaborators of Robert Straßl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Straßl. Robert Straßl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Obermayr, Eva, et al.. (2025). Pretherapeutic Torque Teno Virus (TTV) Counts Assessed By Liquid Biopsy As An Independent Prognostic Biomarker In Ovarian Cancer Patients. International Journal of Gynecological Cancer. 35(2). 101463–101463. 1 indexed citations
2.
Bernhard, J., Michael Schwarz, Lorenz Balcar, et al.. (2024). Reflex testing for anti-HDV in HBsAg-positive patients offers high diagnostic yield in a large Central European tertiary care center. Scientific Reports. 14(1). 25921–25921. 2 indexed citations
3.
Grabmeier‐Pfistershammer, Katharina, et al.. (2023). No evidence of asymptomatic monkeypox infection in a highly sexually active MSM population in Austria. HIV Medicine. 25(1). 150–153. 1 indexed citations
5.
Hartl, Lukas, Mathias Jachs, Benedikt Simbrunner, et al.. (2022). Age‐adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID‐19 patients. Liver International. 42(6). 1297–1307. 16 indexed citations
6.
Vietzen, Hannes, Marianna Traugott, Wolfgang Hoepler, et al.. (2022). The natural killer cell‐associated rs9916629 C allele is a novel genetic risk factor for fatal COVID‐19. Journal of Medical Virology. 95(1). e28404–e28404. 9 indexed citations
7.
Beilhack, Georg F., et al.. (2022). Humoral Response to mRNA-1273 SARS-CoV-2 Vaccine in Peritoneal Dialysis Patients: Is Boostering After Six Months Adequate?. Frontiers in Medicine. 9. 905798–905798. 8 indexed citations
8.
Schmidt, Ralf, Anna Nele Herdina, Georg Greiner, et al.. (2021). Detection of SARS-CoV-2 by real-time PCR under challenging pre-analytical conditions reveals independence of swab media and cooling chain. Scientific Reports. 11(1). 13592–13592. 11 indexed citations
9.
Reiter, Thomas, Ludwig Wagner, Martina Gaggl, et al.. (2021). COVID-19 serology in nephrology healthcare workers. Wiener klinische Wochenschrift. 133(17-18). 923–930. 5 indexed citations
10.
Jachs, Mathias, Teresa Binter, David Chromy, et al.. (2021). Outcomes of an HCV elimination program targeting the Viennese MSM population. Wiener klinische Wochenschrift. 133(13-14). 635–640. 9 indexed citations
11.
Berger, J.M., Margaretha Gansterer, Wolfgang Trutschnig, et al.. (2021). SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic. Wiener klinische Wochenschrift. 133(17-18). 909–914.
12.
Perkmann, Thomas, Nicole Perkmann‐Nagele, Marie‐Kathrin Breyer, et al.. (2020). Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity. Clinical Chemistry. 66(11). 1405–1413. 80 indexed citations
13.
Doberer, Konstantin, Martin Schiemann, Robert Straßl, et al.. (2020). Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients—A prospective observational trial. American Journal of Transplantation. 20(8). 2081–2090. 83 indexed citations
14.
Weseslindtner, Lukas, Lea Hedman, Robert Straßl, et al.. (2020). Longitudinal assessment of the CXCL10 blood and urine concentration in kidney transplant recipients with BK polyomavirus replication—a retrospective study. Transplant International. 33(5). 555–566. 20 indexed citations
15.
Bauer, David, David Chromy, Benedikt Simbrunner, et al.. (2020). Recent outbreaks of severe hepatitis A virus infections in Vienna. European Journal of Clinical Microbiology & Infectious Diseases. 40(2). 335–344. 11 indexed citations
16.
Straßl, Robert, Ilkka Helanterä, Stephan W. Aberle, et al.. (2019). Multiplex analysis of Human Polyomavirus diversity in kidney transplant recipients with BK virus replication. Journal of Clinical Virology. 120. 6–11. 10 indexed citations
17.
Weseslindtner, Lukas, et al.. (2019). Next-generation sequencing shows marked rearrangements of BK polyomavirus that favor but are not required for polyomavirus-associated nephropathy. Journal of Clinical Virology. 122. 104215–104215. 5 indexed citations
18.
Steiner, Sabine, Mattias Mandorfer, Robert Straßl, et al.. (2014). Therapeutic potential of and treatment with boceprevir/telaprevir-based triple-therapy in HIV/chronic hepatitis C coinfected patients in a real-world setting. Zeitschrift für Gastroenterologie. 52(5). 56. 2 indexed citations
19.
Mandorfer, Mattias, B.A. Payer, Maximilian C. Aichelburg, et al.. (2014). Therapeutic Potential of and Treatment with Boceprevir/Telaprevir-Based Triple-Therapy in HIV/Chronic Hepatitis C Co-Infected Patients in a Real-World Setting. AIDS Patient Care and STDs. 28(5). 221–227. 8 indexed citations
20.
Rutter, Karoline, Albert Friedrich Stättermayer, Péter Ferenci, et al.. (2013). 896 SUCCESSFUL HCV ERADICATION DUE TO ANTIVIRAL THERAPY IS ASSOCIATED WITH IMPROVED LONG TERM OUTCOME OF PATIENTS WITH CHRONIC HEPATITIS C. Journal of Hepatology. 58. S369–S369. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026